logo
Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

Business Wire16-05-2025

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein.
'We are pleased to welcome Max and Dan to the Board as we embark on this exciting next chapter for Henry Schein,' said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein.
In connection with the investment, William K. 'Dan' Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Health Care industry team in the Americas, who became a member of Henry Schein's Board of Directors on May 2, 2025.
Max Lin leads the Health Care industry team within KKR, and since joining in 2005, he has overseen a number of investments in the areas of dental services and other health care providers, medical products and equipment, and health care software and information technology. Dan Daniel has over three decades of global leadership experience in industrial and health care sectors, including 14 years as Executive Vice President at Danaher, where he oversaw multiple segments and played a key role in advancing the company's culture and business system. In connection with each of their appointments, Mr. Lin was appointed to the Nominating and Governance Committee as Vice Chair; Mr. Daniel was appointed to the Compensation Committee; and each of Mr. Lin and Mr. Daniel was appointed to the Strategic Advisory Committee.
'We are pleased to welcome Max and Dan to the Board as we embark on this exciting next chapter for Henry Schein,' said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. 'Their deep experience in health care, operations, and strategic growth will be invaluable as we continue executing on our BOLD+1 strategy and creating long-term value for our stakeholders.'
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.
For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.
About KKR
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR's website at www.kkr.com www.globalatlantic.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One
The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One

Yahoo

time26 minutes ago

  • Yahoo

The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One

Omada Health (NASDAQ:OMDA) opened its first day of trading with a bangjumping 21% to $23 after pricing its IPO at $19. That move gives the digital chronic-care startup a market cap of roughly $1.3 billion. The $150 million raise was more than just well receivedinvestor demand came in more than 15x oversubscribed, with most allocations going to a concentrated group of institutional buyers. It's another sign that appetite for health-tech IPOs is heating up again. U.S. listings have raised nearly $25 billion year-to-date, and early-stage healthcare names are up an average of 18% since listing. Founded in 2011, Omada offers virtual care between doctor visitsfocused on diabetes, obesity, hypertension, and joint pain. What sets it apart? It's not chasing the GLP-1 gold rush. Instead, Omada supports people already on those drugs, helping them manage side effects, nutrition, and post-treatment maintenance. About 50,000 of its 679,000 members are on GLP-1s. CEO Sean Duffy told Bloomberg that while AI powers much of the back-end, real human interaction is what drives results. Our members tell us they want a personand I have yet to see anyone that feels accountable to ChatGPT, he said. Revenue for Q1 2025 came in just under $55 millionup from $35.1 million a year agowhile net losses narrowed by more than half to $9.4 million. That improving financial picture, combined with a clear niche in chronic care, could be what's drawing top-tier investors. Revelation Partners, Andreessen Horowitz, Fidelity, and USVP are all among the largest shareholders. The IPO was led by Morgan Stanley, Goldman Sachs, and JPMorgan. OMDA now trades on the Nasdaq Global Marketand it's one more sign that digital health might be staging a real comeback. This article first appeared on GuruFocus.

Omada Health Soars 42% in Nasdaq Debut After $150 Million IPO
Omada Health Soars 42% in Nasdaq Debut After $150 Million IPO

Yahoo

time31 minutes ago

  • Yahoo

Omada Health Soars 42% in Nasdaq Debut After $150 Million IPO

Omada Health (OMDA, Financials) surged 42% in its Nasdaq debut Friday after the virtual chronic care company priced its initial public offering at $19 per share, raising $150 million and securing a valuation just above $1 billion. The stock opened at $23 and climbed quickly past $27. Warning! GuruFocus has detected 8 Warning Sign with X. Founded in 2012, Omada offers virtual programs for chronic conditions including prediabetes, diabetes, and hypertension. The IPO, which sold 7.9 million shares, is part of a recent resurgence in health and tech listings, following last month's debut of Hinge Health and Thursday's surge in Circle Internet shares. In its prospectus, Omada reported Q1 revenue jumped 57% year over year to $55 million, while full-year 2024 revenue rose 38% to $169.8 million. The company narrowed its net loss in the most recent quarter to $9.4 million from $19 million a year earlier. Major outside shareholders include U.S. Venture Partners, Andreessen Horowitz, and Fidelity's FMR LLC, each holding a 9% to 10% stake. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Grab's $7B Mega Move Could Flip Southeast Asia's Tech Empire--But Indonesia Might Block It
Grab's $7B Mega Move Could Flip Southeast Asia's Tech Empire--But Indonesia Might Block It

Yahoo

time31 minutes ago

  • Yahoo

Grab's $7B Mega Move Could Flip Southeast Asia's Tech Empire--But Indonesia Might Block It

Grab (NASDAQ:GRAB) is quietly pushing forward on what could be one of Southeast Asia's biggest tech shakeupsa $7 billion move to acquire rival GoTo. After years of circling each other, the two ride-hailing and food delivery giants are now refining a two-step deal: GoTo could first absorb Grab's Indonesia unit, then Grab would swoop in for control of the merged business. But it's not just about market strategy. The deal faces serious political and regulatory headwinds, especially in Indonesia, where a merger would concentrate 6070% of the on-demand market in one player's hands. Warning! GuruFocus has detected 5 Warning Sign with GRAB. Enter DanantaraIndonesia's sovereign wealth fundwhich has kicked off early-stage talks to buy a minority stake in the new entity. That move could help ease nationalist fears over foreign dominance, job losses, and rising consumer costs. For President Prabowo's government, which has been flexing its populist muscles with wage hikes, subsidy boosts, and demands for driver bonuses, having a local backer in the mix might be a political win. For Grab, it's a potential green light. But the clock is ticking. Any deal still hinges on clearance from Indonesia's antitrust watchdog, and regulatory nerves remain high. Meanwhile, the market dynamics are shifting fast. Grab's revenue in Indonesia rose just 6.3% in 2024its slowest in Southeast Asiawhile GoTo has already exited Vietnam and Thailand. A tie-up would give Grab more firepower in Indonesia's 275-million-strong market, just as newer players like InDrive and Maxim try to muscle in. The stakes? If Danantara comes onboard, the merger could reshape Southeast Asia's tech landscape. If not, Grab might have to find another way into the driver's seat. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store